← All diseases Cancer

Prostate cancer (metastatic)

Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence

Search Period All yearsLast 12 monthsLast 5 years Topic All topicsGeneralNutrition and dietAlternative treatment methods Type of research Any type of researchEvidence of the highest level only (137)Meta-analysis (28)Treatment guideline (1)Randomized trial (67)Phase 3 study (21)Systematic review (20)Clinical trial (627)Review article (238)Early study (phase 1 or 2) (44)Single patient description (132)Laboratory or animal study (27)Commentary or editorial (29)Retracted publication (3) Studies currently recruiting participants only (49)

Filter

Publications (1472)

• Anticancer Activity of the Marine Triterpene Glycoside Cucumarioside A(2)-2 in Human Prostate Cancer Cells. (2023/12/28) ♡
• Gender and Sex Differences in Health-related Quality of Life, Clinical Outcomes and Survival after Treatment of Metastatic Spine Disease. (2023/12/27) ♡
• Randomized researchiParticipants were divided into groups by lottery and compared with each other. This reduces the chance that a difference is due to something other than the treatment. Multimedia-based hormone therapy information program for patients with prostate cancer: the result of a randomized pilot study. (2023/12/27) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. A Potential "Anti-Warburg Effect" in Circulating Tumor Cell-mediated Metastatic Progression? (2023/12/27) ♡
• Office-based Magnetic Resonance Imaging-guided Transperineal Prostate Biopsy Without Antibiotic Prophylaxis: A Real-world Clinical Utility Study. (2023/12/23) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. A case report of a prostate cancer metastasis in the pancreas exhibiting vascular encasement. (2023/12/22) ♡
• The Probability of Metastases Within Different Prostate-specific Antigen Ranges Using Prostate-specific Membrane Antigen Positron Emission Tomography in Patients with Newly Diagnosed Prostate Cancer. (2023/12/22) ♡
• 27-hydroxycholesterol and DNA damage repair: implication in prostate cancer. (2023/12/21) ♡
• Cell-Free DNA Genomic Profiling and Its Clinical Implementation in Advanced Prostate Cancer. (2023/12/21) ♡
• miR-410 Is a Key Regulator of Epithelial-to-Mesenchymal Transition with Biphasic Role in Prostate Cancer. (2023/12/21) ♡
• FABP5 Inhibition against PTEN-Mutant Therapy Resistant Prostate Cancer. (2023/12/21) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Prostate Artery Embolization via Distal Transradial Artery Access in a 100-Year-Old Patient. (2023/12/21) ♡
• Significant reduction in burden of metastatic disease by intermittent docetaxel therapy in a patient with castration-resistant prostate cancer. (2023/12/21) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Synthetic Lethality by Co-Inhibition of Androgen Receptor and Polyadenosine Diphosphate-Ribose in Metastatic Prostate Cancer. (2023/12/20) ♡
• ASSESSMENT OF CELL SURFACE TARGETS IN METASTATIC PROSTATE CANCER: EXPRESSION LANDSCAPE AND MOLECULAR CORRELATES. (2023/12/19) ♡
• Active DHEA uptake in the prostate gland correlates with aggressive prostate cancer. (2023/12/15) ♡
• Expressions of glucose transporter genes are diversely attenuated and significantly associated with prostate cancer progression. (2023/12/15) ♡
• Role of adenosine deaminase in prostate cancer progression. (2023/12/15) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Potential roles of FGF5 as a candidate therapeutic target in prostate cancer. (2023/12/15) ♡
• Systematic reviewiAll research on one question is searched according to fixed rules and compared side by side, so that no studies with poor outcomes are missed. The prognostic value of Eastern Cooperative Oncology Group performance status on overall survival among patients with metastatic prostate cancer: a systematic review and meta-analysis. (2023/12/15) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Diplopia and Ptosis: An Unusual Case of Prostate Cancer Metastasis to the Sphenoid Bone Treated With Palliative Radiotherapy. (2023/12/15) ♡
• Quantitative imaging for (177)Lu-PSMA treatment response monitoring and dosimetry. (2023/12/14) ♡
• Longitudinal Analysis of Bladder Cancer-Specific Mortality Trends in the United States. (2023/12/13) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Case report: 177Lu DOTA-TATE: a new scheme for the treatment of prostate neuroendocrine cancer. (2023/12/11) ♡
• Stereotactic body radiation therapy to postpone systemic therapy escalation for castration-resistant prostate cancer: A multicenter retrospective analysis. (2023/12/08) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. ARCHERY: a prospective observational study of artificial intelligence-based radiotherapy treatment planning for cervical, head and neck and prostate cancer - study protocol. (2023/12/07) ♡
• Acute effect of high-intensity interval aerobic exercise on serum myokine levels and resulting tumour-suppressive effect in trained patients with advanced prostate cancer. (2023/12/01) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Clinical utility of the prognostic nutritional index in patients with metastatic hormone-sensitive prostate cancer: A retrospective, multicenter, cohort study. (2023/12/01) ♡
• Discovery of dolutegravir-1,2,3-triazole derivatives against prostate cancer via inducing DNA damage. (2023/12/01) ♡
• Addition of Olaparib to the New Hormonal Agent Regimen for Metastatic Castration-Resistant Prostate Cancer: A Systematic Review and Meta-Analysis. (2023/12/01) ♡
• Meta-analysisiAll studies on one question combined and calculated together. This is the strongest form of research that exists: a single loose study can be coincidence, dozens together much less so. The label says something about the design, not about the outcome — which can also be that something does NOT work. Efficacy of multidisciplinary interventions in preventing metabolic syndrome and improving body composition in prostate cancer patients treated with androgen deprivation therapy: A systematic review and meta-analysis. (2023/12/01) ♡
• Randomized researchiParticipants were divided into groups by lottery and compared with each other. This reduces the chance that a difference is due to something other than the treatment. Prostate Safety Events During Testosterone Replacement Therapy in Men With Hypogonadism: A Randomized Clinical Trial. (2023/12/01) ♡
• Prospective Study to Compare Efficacy of Conventional Chemoradiotherapy with Hypofractionated Chemoradiotherapy in Locally Advanced Carcinoma of Oropharynx. (2023/12/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Prostate Cancer: Management of Biochemical Recurrence after Surgery. (2023/12/01) ♡
• Predictive Value of Preoperative Prostate Health Index and Serum Testosterone Testing for Biochemical Recurrence after Radical Prostatectomy for Non-Metastatic Prostate Cancer. (2023/12/01) ♡
• Preclinical Study of Therapeutic Efficacy of a New Russian Radiopharmaceutical (177)Lu-DOTA-PSMA. (2023/12/01) ♡
• Prostate-specific antigen doubling time predicts the efficacy of site-directed therapy for oligoprogressive castration-resistant prostate cancer. (2023/12/01) ♡
• [Cost-Effectiveness Analysis and Budget Impact Analysis of Enzalutamide for the Treatment of Metastatic Hormone-Sensitive Prostate Cancer]. (2023/12/01) ♡
• Commentary or editorialiAn expert's opinion or commentary, not new research. Different therapeutic regimens in the treatment of metastatic prostate cancer. (2023/12/01) ♡
• The prevalence and clinical significance of HER2 expression in prostate adenocarcinoma. (2023/12/01) ♡
• Cancer cell invasion alters the protein profile of extracellular vesicles. (2023/11/27) ♡
• Game-changing insights on vertebral skeletal stem cells in bone metastasis and therapeutic horizons. (2023/11/15) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Lifetime Follow-Up of a Patient with Metastatic Prostate Cancer Undergoing Multiple Surgical Resections: A Case Report. (2023/11/08) ♡
• The Geriatric Nutritional Risk Index Predicts Prognosis in Japanese Patients with LATITUDE High-Risk Metastatic Hormone-Sensitive Prostate Cancer: A Multi-Center Study. (2023/11/08) ♡
• Prostate cancer among Saudis: a registry review. (2023/11/07) ♡
• Randomized researchiParticipants were divided into groups by lottery and compared with each other. This reduces the chance that a difference is due to something other than the treatment. A randomized controlled trial investigating rectus sheath catheters following radical cystectomy. (2023/11/01) ♡
• Prognostic value of comorbidity measures among Australian men with non-metastatic prostate cancer. (2023/10/28) ♡
• Olaparib plus Abiraterone for Metastatic Castration-resistant Prostate Cancer: Pharmacokinetics Data from the PROpel Trial. (2023/10/27) ♡
• Low PSA radiographic disease progression on C11-choline PET. (2023/10/25) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Application of the ASCO value framework to evaluate the clinical and economic value of enzalutamide and apalutamide in the early stages of prostate cancer in Colombia. (2023/10/23) ♡

↑ Back to top

codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.